MPN clinical trials are multi-center, an open study testing the long-term safety, tolerability, and efficacy of Givinostat in patients with Polycythemia, Vera, Essential Thrombocythemia, primary Myelofibrois, Vera Myelofibrosis and Post-Essential Thrombocythemia Myelofibrosis following core protocols.
The clinical trials are pilot studies and feasibility studies, prevention trials, screening trials, treatment trials, cohort studies, case-control studies, and cross-sectional studies. The benefits of a clinical trial are getting a new treatment for a disease before it is available to everyone; you play a more active role in your own health care.
Tips when considering a trial are finding out as much as possible about your cancer, asking a lot of questions, having a plan, hospital visits, and keeping a diary.
To conclude, talk to a clinical trial representative and see if this trial option would work for you. The potential benefits are amazing!